Annual Revenue
$43.05B$2.96B+7.38%
Summary
- Current Value
- As of today, GSK annual revenue is $43.05B, up +7.38% on
- Historical Performance
- GSK annual revenue is up +19.19% over the past 3 years, down -1.54% over the past 5 years
- All-Time High Comparison
- GSK annual revenue is currently -5.30% below its historical high of $45.46B set on
- 3-Year Low Comparison
- GSK annual revenue is +19.19% above its 3-year low of $36.12B reached on an earlier date
- Sector Comparison
- GSK annual revenue is higher than 97.97% of companies in Healthcare sector
- Upcoming Earnings
- As of today, the next annual earnings release for GSK has not been scheduled
Revenue Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Revenue | $43.05B | +7.4% | +19.2% | -1.5% | -1.8% | |
| Quarterly Revenue | $11.29B | +5.9% | +25.6% | +38.3% | +3.0% | |
| TTM Revenue | $44.55B | +8.8% | +26.3% | +8.4% | +2.5% | |
| Price | $49.52 | +26.2% | +39.7% | +15.7% | +17.6% | |
| Annual EPS | $3.66 | +130.3% | -59.4% | +0.0% | +197.3% | |
| PE Ratio | 15.60 | -14.7% | +294.9% | +7.2% | -6.8% | |
| Annual Gross Profit | $30.76B | +9.9% | +28.3% | +3.8% | -3.6% | |
| Annual Net Income | $8.29B | +119.8% | +36.7% | +1.2% | +189.8% | |
| Annual EBITDA | $14.43B | +37.5% | +32.7% | +6.8% | +40.3% | |
| Annual EBIT | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% |
Revenue Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $43.05B | at high | |
| 5Y | $43.73B | N/A | -1.5% |
| All | $45.46B | -5.3% |
Revenue Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $36.12B | N/A | +19.2% |
| 5Y | $33.96B | +26.8% | |
| All | $1.33B | +3138.7% |
Revenue Estimates
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $37.70B | - | |
| - | $40.09B | - | |
| - | $43.05B | - |
🔒 Log In To Unlock Full Data
Revenue History
FAQ
- What is the current annual revenue of GSK?
- As of today, GSK annual revenue is $43.05B
- What is 1-year change in GSK annual revenue?
- GSK annual revenue is up +7.38% year-over-year
- What is 3-year change in GSK annual revenue?
- GSK annual revenue is up +19.19% over the past 3 years
- How far is GSK annual revenue from its all-time high?
- GSK annual revenue is currently -5.30% below its historical high of $45.46B set on December 31, 2007
- How does GSK annual revenue rank versus sector peers?
- GSK annual revenue is higher than 97.97% of companies in Healthcare sector
- When is GSK next annual earnings release?
- As of today, the next annual earnings release for GSK has not been scheduled
Quarterly Revenue
$11.29B$1.01B+9.80%
Summary
- Current Value
- As of today, GSK quarterly revenue is $11.29B, up +9.80% on
- Historical Performance
- GSK quarterly revenue is up +5.87% year-over-year, up +25.61% over the past 3 years
- All-Time High Comparison
- GSK quarterly revenue is currently -14.70% below its historical high of $13.23B set on
- 3-Year Low Comparison
- GSK quarterly revenue is +25.61% above its 3-year low of $8.99B reached on an earlier date
- Sector Comparison
- GSK quarterly revenue is higher than 97.93% of companies in Healthcare sector
- Upcoming Earnings
- The next earnings release for GSK is on
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Revenue | $11.29B | +9.8% | +5.9% | +25.6% | +38.3% | |
| Annual Revenue | $43.05B | – | +7.4% | +19.2% | -1.5% | |
| TTM Revenue | $44.55B | +1.4% | +8.8% | +26.3% | +8.4% | |
| Price | $49.52 | -2.8% | +26.2% | +39.7% | +15.7% | |
| Quarterly EPS | $0.29 | -75.0% | -69.3% | -71.1% | -70.2% | |
| PE Ratio | 15.60 | +17.0% | -14.7% | +294.9% | +7.2% | |
| Quarterly Gross Profit | $8.47B | +9.7% | +9.0% | +28.7% | +46.1% | |
| Quarterly Net Income | $742.26M | -70.0% | -66.2% | -66.0% | -58.2% | |
| Quarterly EBIT | $3.22B | +10.9% | +12.3% | +52.4% | +67.3% | |
| Quarterly EBITDA | $3.52B | -0.2% | -20.3% | +31.4% | +31.0% |
Quarterly Revenue Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $11.53B | -2.1% | |
| 3Y | $11.53B | -2.1% | |
| 5Y | $11.53B | -2.1% | |
| All | $13.23B | -14.7% |
Quarterly Revenue Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $10.28B | +9.8% | |
| 3Y | $8.99B | N/A | +25.6% |
| 5Y | $8.16B | N/A | +38.3% |
| All | $454.71M | +2382.2% |
Quarterly Revenue Estimates
| Month | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $11.53B | - | |
| - | $11.46B | - | |
| - | $10.28B | - | |
| - | $11.29B | - |
🔒 Log In To Unlock Full Data
Quarterly Revenue History
FAQ
- What is the current quarterly revenue of GSK?
- As of today, GSK quarterly revenue is $11.29B
- What is GSK quarterly revenue most recent change?
- GSK quarterly revenue was up +9.80% on June 30, 2026
- What is 1-year change in GSK quarterly revenue?
- GSK quarterly revenue is up +5.87% year-over-year
- How far is GSK quarterly revenue from its all-time high?
- GSK quarterly revenue is currently -14.70% below its historical high of $13.23B set on December 31, 2009
- How does GSK quarterly revenue rank versus sector peers?
- GSK quarterly revenue is higher than 97.93% of companies in Healthcare sector
- When is GSK next earnings release?
- The next earnings release for GSK is on
TTM Revenue
$44.55B$625.61M+1.42%
Summary
- Current Value
- As of today, GSK TTM revenue is $44.55B, up +1.42% on
- Historical Performance
- GSK TTM revenue is up +8.82% year-over-year, up +26.25% over the past 3 years
- All-Time High Comparison
- GSK TTM revenue is currently -3.90% below its historical high of $46.36B set on
- 3-Year Low Comparison
- GSK TTM revenue is +26.25% above its 3-year low of $35.29B reached on an earlier date
- Sector Comparison
- GSK TTM revenue is higher than 98.03% of companies in Healthcare sector
- Upcoming Earnings
- The next earnings release for GSK is on
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM Revenue | $44.55B | +1.4% | +8.8% | +26.3% | +8.4% | |
| Annual Revenue | $43.05B | – | +7.4% | +19.2% | -1.5% | |
| Quarterly Revenue | $11.29B | +9.8% | +5.9% | +25.6% | +38.3% | |
| Price | $49.52 | -2.8% | +26.2% | +39.7% | +15.7% | |
| TTM EPS | $3.17 | -17.0% | +48.0% | -64.6% | +8.0% | |
| PE Ratio | 15.60 | +17.0% | -14.7% | +294.9% | +7.2% | |
| TTM Gross Profit | $32.65B | +2.2% | +11.2% | +29.8% | +16.9% | |
| TTM Net Income | $7.08B | -17.1% | +37.3% | +1.3% | +9.4% | |
| TTM EBITDA | $14.11B | -6.0% | +12.8% | +31.3% | +15.4% | |
| TTM EBIT | $11.14B | +3.3% | +46.4% | +42.4% | +25.5% |
TTM Revenue Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $44.55B | at high | |
| 3Y | $44.55B | at high | |
| 5Y | $44.55B | at high | |
| All | $46.36B | -3.9% |
TTM Revenue Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $40.94B | N/A | +8.8% |
| 3Y | $35.29B | N/A | +26.3% |
| 5Y | $35.00B | +27.3% | |
| All | $540.44M | +8144.0% |
TTM Revenue History
FAQ
- What is the current TTM revenue of GSK?
- As of today, GSK TTM revenue is $44.55B
- What is GSK TTM revenue most recent change?
- GSK TTM revenue was up +1.42% on June 30, 2026
- What is 1-year change in GSK TTM revenue?
- GSK TTM revenue is up +8.82% year-over-year
- How far is GSK TTM revenue from its all-time high?
- GSK TTM revenue is currently -3.90% below its historical high of $46.36B set on March 31, 2010
- How does GSK TTM revenue rank versus sector peers?
- GSK TTM revenue is higher than 98.03% of companies in Healthcare sector
- When is GSK next earnings release?
- The next earnings release for GSK is on
Data Sources & References
- GSK Official Website www.gsk.com
- GSK Profile on Yahoo Finance finance.yahoo.com/quote/GSK
- GSK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gsk
